Applications of 4-(2-Carboxyethyl)Benzeneboronic Acid in Industrial Manufacturing

4-(2-Carboxyethyl)benzeneboronic acid is a functionalized boronic acid widely integrated into advanced chemical manufacturing, enabling precision in molecular design and process control. Our factory supplies this raw material for critical roles in pharmaceutical research, diagnostic reagent production, specialty polymer synthesis, and organic electronic materials—each sector presenting unique compliance, formulation, and downstream process requirements detailed below.

1. Pharmaceutical Intermediates Synthesis

This compound serves as a boronic acid building block during the multi-step synthesis of advanced pharmaceutical intermediates, especially for active pharmaceutical ingredient (API) precursor programs involving Suzuki–Miyaura cross-coupling reactions. Line chemists use it to introduce specific aromatic moieties with carboxyalkyl functional groups, directly impacting final molecule bioactivity and selectivity. The inclusion stage is tightly regulated, requiring controlled addition to maintain stoichiometry within complex batch and continuous flow systems.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (EP)
• United States Pharmacopeia (USP) for APIs
• 21 CFR Part 211 (FDA)

Typical usage ratio

• 0.3–3.0 equivalents relative to the haloarene or halopyridine coupling partner, adjusted according to the specific target molecule mass yield and impurity profile

Downstream process integration

• Slurry or solution charged during the Suzuki–Miyaura or related boronate ester formation step, followed by intermediate isolation, purification (typically crystallization or preparative HPLC), and onward conversion to API final forms

Final product types

• NCE (New Chemical Entity) intermediates
• Pharmaceutical bulk APIs including kinase inhibitors and immunomodulators
• Synthetic organic active intermediate libraries
• Chiral drug intermediate scaffolds

2. Diagnostic Reagent Synthesis

Within the diagnostic reagent field, this boronic acid derivative acts as a functional monomer or linker in the assembly of carbohydrate or glycoprotein sensing systems. Its carboxyethyl group provides a handle for covalent coupling with fluorescent dyes or affinity tags, essential in diagnostic kits for glucose, saccharides, and related clinical tests. The dosing and functionalization protocol must tightly conform to diagnostic performance specifications and materials safety requirements.

Industry compliance standards

• ISO 13485:2016 Medical Devices – Quality Management Systems
• CLSI EP05-A3 Evaluation protocols
• EU In Vitro Diagnostic Regulation (IVDR) 2017/746
• US FDA 21 CFR 820 (Quality System Regulation)

Typical usage ratio

• 0.05–0.5% w/w in the final polymer matrix or diagnostic reagent mixture, controlled by sensitivity, detection range, and surface chemistry optimization

Downstream process integration

• Integrated by covalent bonding or physical blending during the polymerization of sensor films, or conjugated to carrier proteins using carbodiimide or NHS-ester activation protocols during probe/chromophore assembly

Final product types

• Glucose biosensor membranes
• Enzyme-linked immunosorbent assay (ELISA) plates featuring boronate affinity
• Point-of-care test strips for sugar alcohols
• Fluorometric carbohydrate detection kits

3. Organic Electronic Materials Production

Producers of organic semiconductors and conductive polymers employ this carboxy-functionalized boronic acid for the creation of π-conjugated systems via palladium-catalyzed cross-coupling. The resulting materials exhibit tailored electron mobility, film-forming capabilities, and interfacial compatibility for device fabrication. Material engineers precisely meter the reactive boronic acid to optimise batch yield, purity, and reproducibility in optoelectronic device prepolymerization.

Industry compliance standards

• ISO 9001:2015 – Quality Management Systems
• IEC 62899 – Printed electronics standards
• RoHS Directive 2011/65/EU for hazardous substances
• Green Chemistry Principles (as adopted in electronic material supply)

Typical usage ratio

• 0.8–1.2 equivalents relative to brominated or iodinated monomers in palladium cross-coupling, adjusted based on desired polymer backbone architecture and substitution pattern

Downstream process integration

• Dosed during the key polymer growth or oligomer assembly stage, directly impacting conjugation length, solubility, and device-relevant physical properties; subsequent work-up involves solvent removal, filtration, and purity QC prior to device fabrication

Final product types

• Organic field-effect transistor (OFET) materials
• Photovoltaic polymer intermediates
• OLED-active layer precursors
• Flexible printed circuit components

4. Specialty Polymer Modification and Synthesis

Advanced polymer manufacturers incorporate this boronic acid to introduce functionalities such as reversible cross-linking, saccharide recognition, or hydrophilic pendant groups into water-soluble or smart polymer systems. Precise incorporation rates are determined by molecular weight targets, charge density, and intended mechanical or responsive characteristics. The acid enters early in the manufacturing process, ensuring even distribution throughout the polymer chain or network, and undergoes subsequent post-modification or purification as required by downstream clients.

Industry compliance standards

• ISO 14001:2015 for Environmental Management
• REACH Regulation (EC) No 1907/2006 for polymeric substances
• ASTM D638 for mechanical testing of polymers
• EN 71-3 Safety standards (for applications in consumer polymer derivatives)

Typical usage ratio

• 0.1–2.0 mol% relative to monomer feed during co-polymerization or post-polymerization grafting, optimized for intended responsive or binding functionality

Downstream process integration

• Charged directly into the main monomer/pre-polymer solution for radical, condensation, or reversible addition–fragmentation chain-transfer (RAFT) polymerization; followed by crosslinking, precipitation, or membrane casting as per client specification

Final product types

• Hydrogel microparticles for bioseparation
• Sugar-binding affinity resins
• Boronate functional block copolymers
• Smart drug delivery carriers